S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69

NextGen Healthcare Stock Forecast, Price & News

+0.14 (+0.79%)
(As of 01/21/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
386,348 shs
Average Volume
395,182 shs
Market Capitalization
$1.23 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive NXGN News and Ratings via Email

Sign-up to receive the latest news and ratings for NextGen Healthcare and its competitors with MarketBeat's FREE daily newsletter.

NextGen Healthcare logo

About NextGen Healthcare

NextGen Healthcare, Inc. engages in the development and marketing of electronic health records, practice management, revenue cycle management, and interoperability solutions. It offers the core; automation and workflow; analytics, population health, and patient engagement, interoperability; managed services; professional services; and client service and support. The company was founded by Sheldon Razin in 1974 and is headquartered in Atlanta, GA.


See More Headlines

Industry, Sector and Symbol

Computer integrated systems design
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$556.82 million
Cash Flow
$1.46 per share
Book Value
$6.44 per share


Net Income
$9.52 million
Pretax Margin




Free Float
Market Cap
$1.23 billion

Company Calendar

Last Earnings
Next Earnings (Confirmed)
Fiscal Year End


Overall MarketRank

2.28 out of 5 stars

Medical Sector

317th out of 1,419 stocks

Computer Integrated Systems Design Industry

13th out of 47 stocks

Analyst Opinion: 2.1Community Rank: 3.9Dividend Strength: 0.0Insider Behavior: 4.2Valuation: 1.3 5 -4 -3 -2 -1 -

NextGen Healthcare (NASDAQ:NXGN) Frequently Asked Questions

Is NextGen Healthcare a buy right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for NextGen Healthcare in the last twelve months. There are currently 2 sell ratings, 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NextGen Healthcare stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NXGN, but not buy additional shares or sell existing shares.
View analyst ratings for NextGen Healthcare
or view top-rated stocks.

How has NextGen Healthcare's stock been impacted by COVID-19?

NextGen Healthcare's stock was trading at $11.01 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, NXGN shares have increased by 63.0% and is now trading at $17.95.
View which stocks have been most impacted by COVID-19

When is NextGen Healthcare's next earnings date?

NextGen Healthcare is scheduled to release its next quarterly earnings announcement on Tuesday, January 25th 2022.
View our earnings forecast for NextGen Healthcare

How can I listen to NextGen Healthcare's earnings call?

NextGen Healthcare will be holding an earnings conference call on Tuesday, January 25th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

How were NextGen Healthcare's earnings last quarter?

NextGen Healthcare, Inc. (NASDAQ:NXGN) posted its earnings results on Thursday, October, 28th. The company reported $0.29 EPS for the quarter, topping analysts' consensus estimates of $0.23 by $0.06. The firm earned $149.29 million during the quarter, compared to the consensus estimate of $143.47 million. NextGen Healthcare had a negative net margin of 0.69% and a positive trailing twelve-month return on equity of 12.59%. The company's quarterly revenue was up 6.6% on a year-over-year basis. During the same quarter last year, the business posted $0.24 EPS.
View NextGen Healthcare's earnings history

What guidance has NextGen Healthcare issued on next quarter's earnings?

NextGen Healthcare updated its FY 2022 earnings guidance on Thursday, November, 4th. The company provided earnings per share (EPS) guidance of $0.900-$0.960 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.930. The company issued revenue guidance of $584 million-$590 million, compared to the consensus revenue estimate of $582.40 million.

What price target have analysts set for NXGN?

8 analysts have issued 1 year price targets for NextGen Healthcare's stock. Their forecasts range from $18.00 to $23.00. On average, they anticipate NextGen Healthcare's stock price to reach $20.71 in the next year. This suggests a possible upside of 15.4% from the stock's current price.
View analysts' price targets for NextGen Healthcare
or view top-rated stocks among Wall Street analysts.

Who are NextGen Healthcare's key executives?

NextGen Healthcare's management team includes the following people:
  • David William Sides, President, Chief Executive Officer & Director
  • L. Allen Plunk, Executive Vice President-Operations
  • James R. Arnold, Chief Financial Officer & Executive Vice President
  • Robert L. Murry, Chief Medical Officer
  • David A. Metcalfe, Chief Technology Officer & Executive VP

What is Rusty Frantz's approval rating as NextGen Healthcare's CEO?

248 employees have rated NextGen Healthcare CEO Rusty Frantz on Glassdoor.com. Rusty Frantz has an approval rating of 72% among NextGen Healthcare's employees.

What other stocks do shareholders of NextGen Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NextGen Healthcare investors own include Altria Group (MO), Verizon Communications (VZ), Exxon Mobil (XOM), Best Buy (BBY), Enbridge (ENB), Enterprise Products Partners (EPD), Huntington Bancshares (HBAN), Netflix (NFLX), Tapestry (TPR) and Twitter (TWTR).

What is NextGen Healthcare's stock symbol?

NextGen Healthcare trades on the NASDAQ under the ticker symbol "NXGN."

Who are NextGen Healthcare's major shareholders?

NextGen Healthcare's stock is owned by a number of retail and institutional investors. Top institutional investors include Russell Investments Group Ltd. (0.18%), State of Alaska Department of Revenue (0.06%), Louisiana State Employees Retirement System (0.04%), Diversified Trust Co (0.02%) and IFP Advisors Inc (0.01%). Company insiders that own NextGen Healthcare stock include Craig A Barbarosh, David Ahmadzai, David William Sides, George H Bristol, James Robert Jr Arnold, Jeffrey D Linton, Jeffrey H Margolis, John R Frantz, Lance Rosenzweig, Mitchell Waters, Sean Brynjelsen and Srinivas S Velamoor.
View institutional ownership trends for NextGen Healthcare

Which institutional investors are selling NextGen Healthcare stock?

NXGN stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Diversified Trust Co, and State of Alaska Department of Revenue. Company insiders that have sold NextGen Healthcare company stock in the last year include Craig A Barbarosh, David Ahmadzai, John R Frantz, Lance Rosenzweig, and Mitchell Waters.
View insider buying and selling activity for NextGen Healthcare
or view top insider-selling stocks.

Which institutional investors are buying NextGen Healthcare stock?

NXGN stock was acquired by a variety of institutional investors in the last quarter, including IFP Advisors Inc, and Louisiana State Employees Retirement System. Company insiders that have bought NextGen Healthcare stock in the last two years include David William Sides, James Robert Jr Arnold, Jeffrey D Linton, Jeffrey H Margolis, Sean Brynjelsen, and Srinivas S Velamoor.
View insider buying and selling activity for NextGen Healthcare
or or view top insider-buying stocks.

How do I buy shares of NextGen Healthcare?

Shares of NXGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NextGen Healthcare's stock price today?

One share of NXGN stock can currently be purchased for approximately $17.95.

How much money does NextGen Healthcare make?

NextGen Healthcare has a market capitalization of $1.23 billion and generates $556.82 million in revenue each year. The company earns $9.52 million in net income (profit) each year or ($0.06) on an earnings per share basis.

How many employees does NextGen Healthcare have?

NextGen Healthcare employs 2,564 workers across the globe.

What is NextGen Healthcare's official website?

The official website for NextGen Healthcare is www.nextgen.com.

Where are NextGen Healthcare's headquarters?

NextGen Healthcare is headquartered at 18111 Von Karman Avenue Suite 800, Irvine CA, 92612.

How can I contact NextGen Healthcare?

NextGen Healthcare's mailing address is 18111 Von Karman Avenue Suite 800, Irvine CA, 92612. The company can be reached via phone at (404) 467-1500, via email at [email protected], or via fax at 949-255-2605.

This page was last updated on 1/23/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.